APA (7th ed.) Citation

XQ, Y., Z, R., HK, W., ZC, X., HY, L., QF, D., . . . W, W. (2024). [Enhancing survival outcomes in stage Ⅲ gastric/esophagogastric junction cancer: A retrospective study of immune checkpoint inhibitors and adjuvant chemotherapy based on real-world data]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery, 27(4), 395. https://doi.org/10.3760/cma.j.cn441530-20240208-00064

Chicago Style (17th ed.) Citation

XQ, Yang, Rao Z, Wei HK, Xue ZC, Liu HY, Duan QF, Sun XW, and Wang W. "[Enhancing Survival Outcomes in Stage Ⅲ Gastric/esophagogastric Junction Cancer: A Retrospective Study of Immune Checkpoint Inhibitors and Adjuvant Chemotherapy Based on Real-world Data]." Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery 27, no. 4 (2024): 395. https://doi.org/10.3760/cma.j.cn441530-20240208-00064.

MLA (9th ed.) Citation

XQ, Yang, et al. "[Enhancing Survival Outcomes in Stage Ⅲ Gastric/esophagogastric Junction Cancer: A Retrospective Study of Immune Checkpoint Inhibitors and Adjuvant Chemotherapy Based on Real-world Data]." Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery, vol. 27, no. 4, 2024, p. 395, https://doi.org/10.3760/cma.j.cn441530-20240208-00064.